Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Cross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assays.

Swortwood MJ, Hearn WL, DeCaprio AP.

Drug Test Anal. 2014 Jul-Aug;6(7-8):716-27. doi: 10.1002/dta.1489. Epub 2013 May 15.

PMID:
23677923
2.

Khat and synthetic cathinones: a review.

Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, Carvalho F, Carvalho M.

Arch Toxicol. 2014 Jan;88(1):15-45. doi: 10.1007/s00204-013-1163-9. Epub 2013 Dec 8. Review.

PMID:
24317389
3.

Bioanalysis of new designer drugs.

Wohlfarth A, Weinmann W.

Bioanalysis. 2010 May;2(5):965-79. doi: 10.4155/bio.10.32. Review.

PMID:
21083227
4.

New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.

Cottencin O, Rolland B, Karila L.

Curr Pharm Des. 2014;20(25):4106-11. Review.

PMID:
24001292
5.

Amphetamine designer drugs - an overview and epidemiology.

Christophersen AS.

Toxicol Lett. 2000 Mar 15;112-113:127-31. Review.

PMID:
10720721
6.

Synthetic cathinones: "a khat and mouse game".

Katz DP, Bhattacharya D, Bhattacharya S, Deruiter J, Clark CR, Suppiramaniam V, Dhanasekaran M.

Toxicol Lett. 2014 Sep 2;229(2):349-56. doi: 10.1016/j.toxlet.2014.06.020. Epub 2014 Jun 25. Review.

PMID:
24973490
7.

[Prevalence of new designer drugs and their legal status in Japan].

Kikura-Hanajiri R, Uchiyama N, Kawamura M, Ogata J, Goda Y.

Yakugaku Zasshi. 2013;133(1):31-40. Review. Japanese.

8.

Oral fluid drug analysis in the age of new psychoactive substances.

Øiestad EL, Øiestad ÅM, Gjelstad A, Karinen R.

Bioanalysis. 2016 Apr;8(7):691-710. doi: 10.4155/bio-2015-0027. Epub 2016 Mar 11. Review.

PMID:
26964619
9.

Nephrotoxic effects of designer drugs: synthetic is not better!

Luciano RL, Perazella MA.

Nat Rev Nephrol. 2014 Jun;10(6):314-24. doi: 10.1038/nrneph.2014.44. Epub 2014 Mar 25. Review.

PMID:
24662435
10.

Mephedrone: Public health risk, mechanisms of action, and behavioral effects.

Dybdal-Hargreaves NF, Holder ND, Ottoson PE, Sweeney MD, Williams T.

Eur J Pharmacol. 2013 Aug 15;714(1-3):32-40. doi: 10.1016/j.ejphar.2013.05.024. Epub 2013 Jun 10. Review.

PMID:
23764466
11.

Substituted cathinone products: a new trend in "bath salts" and other designer stimulant drug use.

Gunderson EW, Kirkpatrick MG, Willing LM, Holstege CP.

J Addict Med. 2013 May-Jun;7(3):153-62. doi: 10.1097/ADM.0b013e31829084b7. Review.

PMID:
23732954
12.

The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis.

Abbott R, Smith DE.

J Psychoactive Drugs. 2015 Nov-Dec;47(5):368-71. doi: 10.1080/02791072.2015.1094591. Epub 2015 Nov 18. Review.

PMID:
26579784
13.

Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market.

de Boer D, Bosman IJ, Hidvégi E, Manzoni C, Benkö AA, dos Reys LJ, Maes RA.

Forensic Sci Int. 2001 Sep 15;121(1-2):47-56. Review.

PMID:
11516887
14.

Hair analysis by immunological methods from the beginning to 2000.

Spiehler V.

Forensic Sci Int. 2000 Jan 10;107(1-3):249-59. Review.

PMID:
10689577
15.

Current "legal highs".

Johnson LA, Johnson RL, Portier RB.

J Emerg Med. 2013 Jun;44(6):1108-15. doi: 10.1016/j.jemermed.2012.09.147. Epub 2013 Mar 23. Review.

PMID:
23528960
16.

[Cannabinoid and cathinone designer drugs - the workings and selected methods of analysis].

Nędza J, Polaniak R, Bułdak RJ, Majchrzak M, Margasiń-Ska J, Rojkiewicz M, Celiński R, Grochowska-Niedworok E.

Pol Merkur Lekarski. 2016 Jul 29;41(241):56-59. Review. Polish.

PMID:
27734824
17.

Cathinone neurotoxicity ("The "3Ms").

Karch SB.

Curr Neuropharmacol. 2015 Jan;13(1):21-5. doi: 10.2174/1570159X13666141210225009. Review.

18.

Mephedrone related fatalities: a review.

Busardò FP, Kyriakou C, Napoletano S, Marinelli E, Zaami S.

Eur Rev Med Pharmacol Sci. 2015 Oct;19(19):3777-90. Review.

19.

Synthetic cathinones (bath salts): legal status and patterns of abuse.

Fass JA, Fass AD, Garcia AS.

Ann Pharmacother. 2012 Mar;46(3):436-41. doi: 10.1345/aph.1Q628. Epub 2012 Feb 28. Review.

PMID:
22388331
20.

[Mephedrone: a designer drug of recent use in France].

Debruyne D, Courné MA, Le Boisselier R, Djezzar S, Gérardin M, Boucher A, Karila L, Coquerel A, Mallaret M.

Therapie. 2010 Nov-Dec;65(6):519-24. Epub 2010 Dec 23. Review. French.

PMID:
21176758

Supplemental Content

Support Center